165 related articles for article (PubMed ID: 20842631)
1. Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function.
Milona A; Owen BM; Cobbold JF; Willemsen EC; Cox IJ; Boudjelal M; Cairns W; Schoonjans K; Taylor-Robinson SD; Klomp LW; Parker MG; White R; van Mil SW; Williamson C
Hepatology; 2010 Oct; 52(4):1341-9. PubMed ID: 20842631
[TBL] [Abstract][Full Text] [Related]
2. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
Mencarelli A; Renga B; Migliorati M; Cipriani S; Distrutti E; Santucci L; Fiorucci S
J Immunol; 2009 Nov; 183(10):6657-66. PubMed ID: 19880446
[TBL] [Abstract][Full Text] [Related]
3. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
4. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice.
Martin IV; Schmitt J; Minkenberg A; Mertens JC; Stieger B; Mullhaupt B; Geier A
Biol Chem; 2010 Dec; 391(12):1441-9. PubMed ID: 20868235
[TBL] [Abstract][Full Text] [Related]
5. Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR).
Berrabah W; Aumercier P; Gheeraert C; Dehondt H; Bouchaert E; Alexandre J; Ploton M; Mazuy C; Caron S; Tailleux A; Eeckhoute J; Lefebvre T; Staels B; Lefebvre P
Hepatology; 2014 May; 59(5):2022-33. PubMed ID: 24037988
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype.
Abu-Hayyeh S; Papacleovoulou G; Lövgren-Sandblom A; Tahir M; Oduwole O; Jamaludin NA; Ravat S; Nikolova V; Chambers J; Selden C; Rees M; Marschall HU; Parker MG; Williamson C
Hepatology; 2013 Feb; 57(2):716-26. PubMed ID: 22961653
[TBL] [Abstract][Full Text] [Related]
8. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.
Capello A; Moons LM; Van de Winkel A; Siersema PD; van Dekken H; Kuipers EJ; Kusters JG
Am J Gastroenterol; 2008 Jun; 103(6):1510-6. PubMed ID: 18510604
[TBL] [Abstract][Full Text] [Related]
9. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
[TBL] [Abstract][Full Text] [Related]
10. Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis.
Park YJ; Qatanani M; Chua SS; LaRey JL; Johnson SA; Watanabe M; Moore DD; Lee YK
Hepatology; 2008 May; 47(5):1578-86. PubMed ID: 18393320
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids promote hepatic cholestasis in mice by inhibiting the transcriptional activity of the farnesoid X receptor.
Lu Y; Zhang Z; Xiong X; Wang X; Li J; Shi G; Yang J; Zhang X; Zhang H; Hong J; Xia X; Ning G; Li X
Gastroenterology; 2012 Dec; 143(6):1630-1640.e8. PubMed ID: 22922423
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
Yang F; Huang X; Yi T; Yen Y; Moore DD; Huang W
Cancer Res; 2007 Feb; 67(3):863-7. PubMed ID: 17283114
[TBL] [Abstract][Full Text] [Related]
13. Role of bile acids and bile acid receptors in metabolic regulation.
Lefebvre P; Cariou B; Lien F; Kuipers F; Staels B
Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
[TBL] [Abstract][Full Text] [Related]
14. Agonist of farnesoid X receptor protects against bile acid induced damage and oxidative stress in mouse placenta--a study on maternal cholestasis model.
Wu WB; Xu YY; Cheng WW; Wang YX; Liu Y; Huang D; Zhang HJ
Placenta; 2015 May; 36(5):545-51. PubMed ID: 25747729
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and Estrogen Receptor-α-Mediated Transrepression of Bile Salt Export Pump.
Chen Y; Vasilenko A; Song X; Valanejad L; Verma R; You S; Yan B; Shiffka S; Hargreaves L; Nadolny C; Deng R
Mol Endocrinol; 2015 Apr; 29(4):613-26. PubMed ID: 25675114
[TBL] [Abstract][Full Text] [Related]
17. Yangonin protects against estrogen-induced cholestasis in a farnesoid X receptor-dependent manner.
Dong R; Wang J; Gao X; Wang C; Liu K; Wu J; Liu Z; Sun H; Ma X; Meng Q
Eur J Pharmacol; 2019 Aug; 857():172461. PubMed ID: 31220436
[TBL] [Abstract][Full Text] [Related]
18. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.
Pereira-Fantini PM; Lapthorne S; Joyce SA; Dellios NL; Wilson G; Fouhy F; Thomas SL; Scurr M; Hill C; Gahan CG; Cotter PD; Fuller PJ; Hardikar W; Bines JE
J Hepatol; 2014 Nov; 61(5):1115-25. PubMed ID: 24999016
[TBL] [Abstract][Full Text] [Related]
19. A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression.
Marzolini C; Tirona RG; Gervasini G; Poonkuzhali B; Assem M; Lee W; Leake BF; Schuetz JD; Schuetz EG; Kim RB
Mol Endocrinol; 2007 Aug; 21(8):1769-80. PubMed ID: 17519356
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-Induced Cholestasis Leads to Repressed CYP2D6 Expression in CYP2D6-Humanized Mice.
Pan X; Jeong H
Mol Pharmacol; 2015 Jul; 88(1):106-12. PubMed ID: 25943116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
